bis(4-(trifluoromethoxy)phenyl)methanol | 261925-93-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: bis(4-(trifluoromethoxy)phenyl)methanol
• 英文别名: Bis[4-(trifluoromethoxy)phenyl]methan-1-ol；bis[4-(trifluoromethoxy)phenyl]methanol
• CAS: 261925-93-3
• 化学式: C₁₅H₁₀F₆O₃
• 分子量: 352.233
• InChiKey: DGTZNVQZMFAZMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  bis(4-(trifluoromethoxy)phenyl)methanol 在 草酰氯 、 三乙胺 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 1.0h， 以95%的产率得到bis(4-(trifluoromethoxy)phenyl)methanone
  参考文献：
  名称：

  非核苷类抗病毒环丙基羧酰腙的合成及抗 HSV-1 构效关系的初步研究。

  摘要：

  报道了先导抗病毒环丙基羧基酰基腙 4F17 ( 5 ) 和结构类似物的三个序列阵列的合成，以及针对 1 型单纯疱疹病毒 (HSV-1) 的抗病毒药效团的初步评估和优化。

  DOI：

  10.1016/j.bmcl.2020.127559
• 作为产物：
  描述：

  4-溴苯酚 在 sulfur tetrafluoride 、 magnesium 作用下， 反应 11.0h， 生成 bis(4-(trifluoromethoxy)phenyl)methanol
  参考文献：
  名称：

  Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake

  摘要：

  The introduction of lipophilic groups onto the ring nitrogen of nipecotic acid and guvacine, two known GABA uptake inhibitors, afforded potent, orally-active anticonvulsant drugs. A series of compounds is reported which explores the structure-activity relationships (SAR) in this series. Among the areas explored: side-chain SAR (aromatic-, heterocyclic-, and tricyclic-containing side chains) and modifications to the tetrahydropyridine ring. The benzhydrol ether-containing side chains afforded the most potent compounds with several exhibiting in vitro IC50 values for GABA uptake of <1 muM (including 5, Table 1; 37, 43, Table IV; and 44, Table V). Compound 44 was selected for extensive evaluation and subsequently progressed to Phase 1 clinical trials with severe adverse effects seen after single dose administration to humans.

  DOI：

  10.1021/jm00100a032

文献信息

• Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer
  作者：Sahar B. Kandil、Samuel R. Jones、Sonia Smith、Stephen E. Hiscox、Andrew D. Westwell

  DOI：10.3390/molecules25153488

  日期：——

  Focal adhesion kinase (FAK) is a tyrosine kinase that is overexpressed and activated in several advanced-stage solid cancers. In cancer cells, FAK promotes the progression and metastasis of tumours. In this study, we used structure-based virtual screening to filter a library of more than 210K compounds against the focal adhesion targeting FAK-focal adhesion targeting (FAT) domain to identify 25 virtual

  粘着斑激酶 (FAK) 是一种酪氨酸激酶，在几种晚期实体癌中过度表达和激活。在癌细胞中，FAK 促进肿瘤的进展和转移。在这项研究中，我们使用基于结构的虚拟筛选针对粘着斑靶向 FAK-粘着斑靶向 (FAT) 域过滤了超过 210K 化合物的库，以识别在浸润性乳腺癌细胞系中筛选的 25 种虚拟命中化合物。 MDA-MB-231）。最值得注意的是，化合物 I 显示出低微摩尔的抗增殖活性以及抗迁移活性。此外，在三阴性乳腺癌 (TNBC) 模型中的检查表明，尽管不影响 FAK 磷酸化，但化合物 I 显着损害增殖，同时损害粘着斑生长和周转，导致迁移减少。使用四步合成程序对先导化合物 I 的类似物进行了进一步优化和合成，并评估了类似物对三种乳腺癌（MDA-MB-231、T47D、BT474）细胞系和一种胰腺癌的抗增殖活性(MIAPaCa2) 细胞系。化合物 5f 被鉴定为有前途的先导化合物，其在 MDA-MB-231、T47D、BT474
• Azetidine derivatives, their preparation and medicaments containing them
  申请人：——

  公开号：US20020035102A1

  公开（公告）日：2002-03-21

  The invention concerns compounds of formula (1) wherein: R represents a chain (A) or (B); R 1 is methyl or ethyl; R 2 is either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R 3 and R 4 , identical or different, are either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R′ represents a hydrogen atom or a —CO—alk radical, their optical isomers, their salts, their preparation and medicines containing them. 1

  本发明涉及通式(1)的化合物，其中：R代表链(A)或(B)；R1是甲基或乙基；R2是可任选取代的芳香环或可任选取代的杂芳香环；R3和R4，相同或不同，是可任选取代的芳香环或可任选取代的杂芳香环；R′代表氢原子或—CO—烷基，它们的光学异构体，它们的盐，它们的制备方法以及含有它们的药物。
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• Acetindine derivatives, their preparation and medicaments containing them
  申请人：——

  公开号：US20030162808A1

  公开（公告）日：2003-08-28

  Disclosed are azetidine derivatives of formula: 1 their optical isomers, their salts, their preparation and medicaments containing them.

  本发明涉及一种公开的式（1）的氮杂环丙烷衍生物，其光学异构体，其盐，其制备方法以及含有它们的药物。
• N-Substituted Azacycles
  申请人：Theodoridis George

  公开号：US20090215821A1

  公开（公告）日：2009-08-27

  N-substituted azacycle derivative compounds represented by formula (I): wherein m, q, r, t and u are independently selected from 0 or 1; and p is 0, 1, 2, or 3; and A, B, D, X, Y, R, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 are fully described herein. The compounds being particularly useful in compositions comprising an insecticidally effective amount of at least one compound of formula I, and an insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to a locus where insects are present or are expected to be present.

  式（I）所代表的N-取代的杂环衍生物化合物：其中m、q、r、t和u独立地选择0或1；p为0、1、2或3；A、B、D、X、Y、R、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10和R11在此完全描述。该化合物在包含式I至少一种化合物的杀虫有效量和杀虫相容载体的组合物中特别有用；以及控制昆虫的方法，包括将所述组合物应用于昆虫存在或预计存在的场所。